Supplementary webappendix
|
|
- Sara Melissa Greer
- 6 years ago
- Views:
Transcription
1 Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Henderson EJ, Lord SR, Brodie MA, et al. Rivastigmine for gait stability in patients with Parkinson s disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol 2016; published online Jan 12.
2 Supplementary Appendix 1: Secondary outcome measures Measure Falls and gait measures Description Falls A fall was defined as an unexpected event in which participants come to rest on the ground, floor, or lower level. 1 Data were collected prospectively in diaries and returned monthly, via post. Missing information was rectified via telephone. Physiological falls risk The Physiological Profile Assessment (PPA) consists of five measures of performance including (1) visual contrast sensitivity, (2) proprioception, (3) quadriceps muscle strength, (4) hand reaction time and (5) postural sway. 2 The five PPA components are weighted to compute a composite PPA fall risk score in z score units with higher scores indicating greater falls risk. The PPA was undertaken to understand other factors that may contribute falls risk outside of those typically assessed for PD patients specifically. Visual contrast sensitivity is assessed using the Melbourne Edge Test. The chart has 20 circular patches containing edges with reducing contrast with variable orientation as the identifying feature. Correct identification of the orientation of the edge on the patches provides a measure of contrast sensitivity in decibel units, where 1 db = 10 log10 contrast. Proprioception is measured using a lower-limb matching test, where difference in matching the great toes in degrees is recorded using a vertical clear acrylic sheet inscribed with a protractor and placed between the legs. Quadriceps muscle strength (isometric) in kilograms is examined in the dominant leg using a spring gauge while participants are seated with the hip and the knee joint at 90 of flexion. Simple reaction time in milliseconds is assessed using a light as a stimuli and a finger-depression of a switch as the response. Postural sway (total sway path in millimetres) is assessed using a sway-meter that measures the displacement of the body at waist level while participants stand for 30 seconds on a foam rubber mat with eyes open. Where participants were physically unable to complete the component tests the following scores were used. Proprioception and/ or muscle strength testing: worse score of all participants. Sway: mean +3SD. Participants who scored greater than mean +3SD s for sway were capped so as not to be disadvantaged. Controlled leaning balance Fear of Falling Controlled leaning balance was assessed with the coordinated stability test which requires participants to accurately adjust their position in a steady and coordinated manner when their centre of mass is near the limits of their base of support. 2 In this trial scores ranged from 0 to 79 with higher scores indicating poorer leaning balance. As these data were highly skewed and could not be transformed to meet the assumptions of normality, outcome scores were converted to an ordinally-scaled variable with 4 categories. The Short Form Iconographical Falls Efficacy Scale assesses fear of falling in 10 scenarios presented pictorially. 3 Response is graded on an ordinal 4 point scale from 1: not concerned about falling to 4: very concerned. Total score range with higher scores indicating greater fear of falling.
3 Cognitive measures General cognition Executive function Mood Measured as the total Montreal Cognitive Assessment (MoCA). 4 Scored on a 30 point ordinal scale, range 0-30 with higher scores indicating less impairment. Measured using Frontal Assessment Battery (FAB). 5 Scored on an 18- point ordinal scale with higher scores indicating more severe impairment. Measured using the 15-item Geriatric Depression Score, a 15-point ordinal scale, range 0-15, with higher values indicating more severe depression. 6 Everyday Cognitive failures Measured using the Cognitive Failures Questionnaire, which assesses perceptual, memory and action lapses in day-to day life. Scores range from with higher scores indicating greater cognitive failure. 7 Disease measures Parkinson s disease severity Levodopa equivalent dose Freezing of gait Quality of Life Total score from Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). 8 Consists of 65 items divided into four parts: I: Non-motor Experiences of Daily Living; II: Motor Experiences of Daily Living; III: Motor Examination; IV: Motor Complications. Total score range 0-260, with higher values indicating greater disease severity. Comprehensive drug history was obtained including dose, frequency and route of all medications. The total levodopa equivalent dose in milligrams was calculated according to Tomlinson and colleagues for all PD related medications. 9 As these data were highly skewed and could not be transformed to meet the assumptions of normality, total dose was converted to an ordinally-scaled variable with 4 categories: Very Low <550mg/day; Moderate 551 to 889mg/day; High 900 to 1244mg/day; Very high 1255mg/day. Freezing of gait in the past month is derived from Question 1 of the New Freezing of Gait Questionnaire (N-FOGQ): Did you experience freezing of gait episode over the past month 10 with categorical responses coded as either yes =1 or no. The New Freezing of Gait Questionnaire assesses the duration, frequency and impact of freezing. Total score ranges from 0 to 28, with higher scores representing worse freezing. Total scores are presented only for participants who reported having experienced a freeze in the past month. Measured using the EQ-5D-5L which consists 2 parts, a visual analogue scale and 5 dimension of quality of life. The Visual Analogue Score, ranges from with higher scores indicating better health. The 5 dimensions of quality of life are assessed on a 5 level ordinal scale from which an index score is derived using Office of Health Economics UK value set. Index scores range from to with higher index score indicating better quality of life. 11
4 Supplementary Appendix 2: Baseline categories The table below presents the categorised baseline data for coordinated stability and levodopa equivalent dose. Table 2a. Baseline categorised coordinated stability scores Category Score range Rivastigmine Placebo Low (good performance) /62 6/63 Medium /62 17/63 High /62 15/63 Very high (poor performance) 28 14/62 25/63 Table 2b. Baseline categorised coordinated stability scores Category Score range Rivastigmine Placebo Very low <500mg/day 27/65 9/65 Low 551mg 889mg/day 14/65 19/65 Moderate 900mg 1244mg/day 15/65 18/65 High 1245mg/day 9/65 19/65
5 Supplementary Appendix 3: Sensitivity Analyses 3a. To assess the sensitivity of the primary analysis the multiple linear model was repeated using a multiple imputed dataset. Table 3a. Primary analysis with intention-to-treat and multiple imputed datasets ITT Analysis Sensitivity analysis with MI Adjusted GMR (95% CI) p value Adjusted GMR (95% CI) p value Condition Normal walk 0 72 ( ) ( ) 0 03 Simple cognitive task 0 79 ( ) ( ) 0 15 Complex cognitive task 0 81 ( ) ( ) 0 19 ITT: Intention to Treat. GMR: Geometric Mean Ratio. MI: Multiple Imputation. CI: Confidence Interval This sensitivity analysis did not qualitatively change the interpretation of results but rendered more conservative point estimates of effect. 3b. The primary analysis was repeated adjusting for levodopa equivalent dose and gender which were, by chance, imbalanced at baseline. Table 3a. Primary analysis with repeated analysis adjusted for levodopa equivalence and gender Condition ITT Analysis Sensitivity analysis adjusting for LED and gender Adjusted GMR (95% CI) p value Adjusted GMR (95% CI) p value Normal walk 0 72 ( ) ( Simple cognitive task 0 79 ( ) ( ) 0 04 Complex cognitive task 0 81 ( ) ( ) 0 15 ITT: Intention to Treat. GMR: Geometric Mean Ratio. CI: Confidence Interval LED: Levodopa equivalent dose. This sensitivity analysis did not qualitatively change the interpretation of results but rendered more precise estimates of effect. 3c. The primary falls analysis using negative binomial regression excluded one participant who was an extreme outlier. A sensitivity analysis was therefore undertaken using multinomial logistic regression, which included the extreme outlier. Fall rate was categorised into quantiles: low, falls per month; intermediate, falls per month; high, falls per month, or very high, >2 04 falls per month. The extreme outlier was therefore now included in the very high category. Table 3c. Falls sensitivity analysis using multinomial logistic regression Fall category RRR (95% CI) p value Low falls Referent Intermediate falls 0 91 ( ) 0 88 High falls 0 18 ( ) Very high falls 0 17 ( ) 0 02 RRR: Relative risk ratio. CI: Confidence Interval
6 The multinomial logistic regression supports the negative binomial regression model showing that rivastigmine treatment is associated with a reduction in the risk of being in the intermediate /high/ very high falls category compared to the low fall rate category. 3d. The primary falls analysis using negative binomial regression excluded one participant who was an extreme outlier. A further sensitivity analysis was undertaken assigning this participant an arbitrary high but not extreme value (=number of falls +1 of next highest participant in that group) and the analysis repeated using negative binomial regression. Table 3d. Falls sensitivity analysis assigning outlier next highest value +1 using negative binomial regression Unadjusted incident rate ratio between groups (95% CI) Adjusted incident rate ratio between groups (95% CI) p value Primary Falls Analysis 0 60 ( ) 0 55 ( ) Sensitivity Analysis 0.67 ( ) 0 58 ( ) Adjusted for baseline outcome, centred age, centred baseline cognition (MoCA score), centred baseline log step time variability during normal walking, previous falls categorised as (1, 2-3, 4-6, 7-19, 20+). In this sensitivity analysis, treatment with rivastigmine is associated with a 42% (95%CI 60% 15%) reduction in falls. This is slightly attenuated compared with the primary analysis, which demonstrated a 45% reduction. The overall interpretation of the findings in respect to falls is unchanged.
7 Supplementary Appendix 4: Serious Adverse Events Table 4a Serious Adverse Events by System Organ Class (including falls) Placebo Rivastigmine Participants (%) Events Participants (%) Events Cardiac disorders Angina pectoris Endocrine disorders Thyroid disorder Gastrointestinal disorders* Abdominal pain Infections and infestations Peritonitis Urinary Tract Infections Injury, poisoning and procedural complications Fall Investigations Biopsy of cervix Neoplasms benign, malignant and unspecified (incl cysts and polyps) Lung Neoplasm Malignant Pancreatic Cancer Metastatic Nervous system disorders Parkinsonism Transient Ischaemic Attack Surgical and Medical Procedures Foot operation Hernia repair Limb operation TOTAL 0 (0 0) 0 2 (3 5) 2 4 (6 2) 6 5 (7 7) 5 4 (6 2) 6 5 (7 7) 5 1 (1 5) 1 1 (1 5) 1 2 (3 1) 2 3 (4 6) 3 1 (1 5) 1 3 (4 6) 3 1 (1 5) 1 2 (3 1) Parkinsonism represents worsening of pre-existing Parkinsonism symptoms
8 Overall, 27 Serious Adverse Events (SAE s) occurred. 14/27 (52%) occurred in the rivastigmine arm of which only two were assessed as being probably or definitely related to the treatment, both of which were worsening of Parkinsonism. 13/27 (48%) SAE s occurred in the placebo arm, none of which were probably or definitely related to the placebo medication.
9 Appendix references 1 Lamb SE, Jørstad-Stein EC, Hauer K, Becker C. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc 2005; 53: Lord S, Menz H, Tiedemann A. A physiological profile approach to falls risk assessment and prevention. Phys Ther 2003; 83: Delbaere K, Smith ST, Lord SR. Development and initial validation of the Iconographical Falls Efficacy Scale. J Gerontol A Biol Sci Med Sci 2011; 66: Dalrymple-Alford JC, MacAskill MR, Nakas CT, et al. The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 2010; 75: Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB A frontal assessment battery at bedside. Neurology 2000; 55: Meara J, Mitchelmore E, Hobson P. GDS-15 geriatric depression scale as a screening instrument for depressive symptomatology in patients with Parkinson s disease and their carers in the community. Age Ageing 1999; 28: Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol 1982; 21: Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008; 23: Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson s disease. Mov Disord 2010; 25: Nieuwboer A, Rochester L, Herman T, et al. Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson s disease and their carers. Gait Posture 2009; 30: Office of Health Economics. An EQ-5D-5L Value Set for England. (accessed July 16, 2015).
Update on Falls Prevention Research
Update on Falls Prevention Research Jasmine Menant NSW Falls Prevention Network Rural Forum 8 th March 2018 Acknowledgments: Prof Stephen Lord Recent falls risk factor studies Brain activation in older
More informationSupplementary Online Content
Supplementary Online Content Buhagiar M, Naylor J, Harris I, et al. Effect of inpatient rehabilitation vs a monitored home-based program on mobility in patients with total knee arthroplasty: the HIHO study:
More informationPrevention of falls in older age: The role of physical activity. Dr Anne Tiedemann Senior Research Fellow
Prevention of falls in older age: The role of physical activity Dr Anne Tiedemann Senior Research Fellow Fall definition Prevention of Falls Network Europe (ProFaNE) definition 1 : an unexpected event
More informationAll rights reserved. For permissions, please doi: /gerona/glt007 Advance Access publication May 16, 2013
Journals of Gerontology: MEDICAL SCIENCES The Author 2013. Published by Oxford University Press on behalf of The Gerontological Society of America. Cite journal as: J Gerontol A Biol Sci Med Sci. 2013
More informationSit-to-Stand Performance Depends on Sensation, Speed, Balance, and Psychological Status in Addition to Strength in Older People
Journal of Gerontology: MEDICAL SCIENCES 2002, Vol. 57A, No. 8, M539 M543 Copyright 2002 by The Gerontological Society of America Sit-to-Stand Performance Depends on Sensation, Speed, Balance, and Psychological
More informationSensitivity and Specificity of the Minimal Chair Height Standing Ability Test: A Simple and Affordable Fall-Risk Screening Instrument
Sensitivity and Specificity of the Minimal Chair Height Standing Ability Test: A Simple and Affordable Fall-Risk Screening Instrument By: Nadia C. Reider, MSc ; Patti-Jean Naylor, PhD ; Catherine Gaul,
More informationSponsor Novartis. Generic Drug Name. NA (not existing yet) Therapeutic Area of Trial Parkinson s Disease L-dopa induced dyskinesia
Page 1 Sponsor Novartis Generic Drug Name NA (not existing yet) Therapeutic Area of Trial Parkinson s Disease L-dopa induced dyskinesia Approved Indication Investigational. Study Number CA2206 Title A
More informationModified Parkinson Activity Scale
Modified Parkinson Activity Scale Chair transfers Analyses: Instruction: Chair with 40 cm seat height, or, when at the patient's home, the chair that causes the greatest problems to the patient and is
More informationClinicalTrials.gov "Basic Results" Data Element Definitions (DRAFT)
ClinicalTrials.gov "Basic Results" Data Element Definitions (DRAFT) January 9, 2009 * Required by ClinicalTrials.gov [*] Conditionally required by ClinicalTrials.gov (FDAAA) May be required to comply with
More informationClinical Trial Results Database Page 1
Clinical Trial Results Database Page 1 Sponsor Novartis Pharmaceuticals Corporation Generic Drug Name Therapeutic Area of Trial Major Depressive Disorder (MDD) Approved Indication Treatment of major depressive
More informationRisk Factors for Falls in Cognitive Impairment
Risk Factors for Falls in Cognitive Impairment A/Prof Jacqueline Close Falls and Injury Prevention Group NeuRA Prince of Wales Clinical School University of New South Wales Background Epidemiology of falls
More informationClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: 10/11/2013. ClinicalTrials.gov ID: NCT
ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: 10/11/2013 ClinicalTrials.gov ID: NCT00168454 Study Identification Unique Protocol ID: 191622-077 Brief Title: A
More informationFalls Prevention Research Update, Stephen Lord
Falls Prevention Research Update, 2017 Stephen Lord Gait adaptability impaired as an indicator of fall risk in older people Joana Caetano Stephen Lord Jasmine Menant 53% of falls are caused by trips and
More informationKinesthetic and Visual Imagery Questionnaire (KVIQ) Administration procedures
(KVIQ) Administration procedures The aim of this questionnaire is to determine the extent to which individuals are able to visualize and feel imagined movements. There is no right or wrong answer. This
More informationPrevention of falls in Parkinson s disease: a review of fall risk factors and the role of physical interventions
Review For reprint orders, please contact: reprints@futuremedicine.com Prevention of falls in Parkinson s disease: a review of fall risk factors and the role of physical interventions Colleen G Canning*,1,
More informationClinical Trial Results Database Page 1
Clinical Trial Results Database Page 1 Sponsor Novartis Generic Drug Name Therapeutic Area of Trial L-dopa induced dyskinesias in Parkinson s disease (PD-LID) Approved Indication Not approved yet for any
More informationThe association between choice stepping reaction time and falls. in older adults a path analysis model
The association between choice stepping reaction time and falls in older adults a path analysis model Running Head: Path analysis on choice stepping and falls Keywords: accidental falls, aged, risk factors,
More informationBrunel balance assessment (BBA)
Brunel balance assessment (BBA) Tyson, S Title Authors Type URL Brunel balance assessment (BBA) Tyson, S Published Date 2004 Monograph This version is available at: http://usir.salford.ac.uk/4886/ USIR
More informationCorrelation between motor and cognitive functions in the progressive course of Parkinson s disease
doi:10.1111/ncn3.53 ORIGINAL ARTICLE Correlation between motor and cognitive functions in the progressive course of Parkinson s disease Hidetomo Murakami,* Yoshiyuki Owan,* Yukiko Mori,* Kazuhisa Fujita,*
More informationRe-Submission. Scottish Medicines Consortium. rasagiline 1mg tablet (Azilect ) (No. 255/06) Lundbeck Ltd / Teva Pharmaceuticals Ltd.
Scottish Medicines Consortium Re-Submission rasagiline 1mg tablet (Azilect ) (No. 255/06) Lundbeck Ltd / Teva Pharmaceuticals Ltd 10 November 2006 The Scottish Medicines Consortium (SMC) has completed
More informationThe study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationAmerican Council on Exercise
American Council on Exercise February 23, 2015 Fitnovatives Blog Exercise Progressions for Clients Who Are Overweight or Are Affected by Obesity While there is no single right way to train clients who
More informationBerg Balance Scale. CVA, Parkinson Disease, Pediatrics
CVA, Parkinson Disease, Pediatrics CVA Highly recommended for inpatient and outpatient rehabilitation Recommended for acute care Parkinson s Disease Recommended for H and Y stages 2 and 3 G code-changing
More informationStudy protocol. Resistance versus Balance Training to improve postural control in Parkinson s disease
Study protocol (English translation of the german study protocol; for the complete study protocol see german version) Resistance versus Balance Training to improve postural control in Parkinson s disease
More informationSafinamide (Addendum to Commission A15-18) 1
IQWiG Reports Commission No. A15-41 Safinamide (Addendum to Commission A15-18) 1 Addendum Commission:A15-41 Version: 1.1 Status: 29 October 2015 1 Translation of addendum A15-41 Safinamid (Addendum zum
More informationSearch for studies: ClinicalTrials.gov Identifier: NCT
ClinicalTrials.gov A service of the U.S. National Institutes of Health Search for studies: Example. "Heart attack" AND "Los Angeles" Advanced Search Help Studies by Topic Glossary Find Studies About Clinical
More informationThe Falls Efficacy Scale International (FES-I). A comprehensive longitudinal validation study
Age and Ageing 2010; 1 7 doi: 10.1093/ageing/afp225 Age and Ageing Advance Access published January 8, 2010 The Author 2010. Published by Oxford University Press on behalf of the British Geriatrics Society.
More informationBORDEAUX MDS WINTER SCHOOL FOR YOUNG
BORDEAUX MDS WINTER SCHOOL FOR YOUNG NEUROLOGISTS INFUSION THERAPIES IN PARKINSON S DISEASE Apomorphine, T. Henriksen Tove Henriksen, MD MDS Clinic University Hospital of Bispebjerg, Copenhagen MOTOR FLUCTUATIONS
More informationOverview The BBS is a widely-used, clinician-rated scale used to assess sitting and standing, static and dynamic balance.
Core Measure: Berg Balance Scale (BBS) Overview The BBS is a widely-used, clinician-rated scale used to assess sitting and standing, static and dynamic balance. Number of Test Items The BBS consists of
More informationWhat goes wrong with balance in Parkinson s Disease? Fay B Horak, PhD, PT Professor of Neurology Oregon Health and Science. CoM
What goes wrong with balance in Parkinson s Disease? Fay B Horak, PhD, PT Professor of Neurology Oregon Health and Science CoM CoM Course Objectives Understand different types of balance systems affected
More informationSupplementary webappendix
Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Ray K K, Seshasai S R K, Wijesuriya S,
More informationAdvanced Core. Healthy Weight Center
Advanced Core Superman Lay face down on matt Lift the legs and hands in unison making a U-shape Slowly bring the legs and hands back to the floor and repeat. V-Sit Abs Begin by sitting on a matt Bring
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationCORE MEASURE: CORE MEASURE: BERG BALANCE SCALE (BBS)
OVERVIEW NUMBER OF TEST ITEMS SCORING EQUIPMENT TIME (NEW CLINICIAN) TIME (EXPERIENCED CLINICIAN) COST o The BBS is a widely-used, clinician-rated scale used to assess sitting and standing, static and
More informationSusan W. Muir PT PhD. Post-Doctoral Fellow Division of Geriatric Medicine Schulich School of Medicine & Dentistry University of Western Ontario
Susan W. Muir PT PhD Post-Doctoral Fellow Division of Geriatric Medicine Schulich School of Medicine & Dentistry University of Western Ontario University of Toronto Rehabilitation Rounds June 14, 2012
More informationEfficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis
A service of the U.S. National Institutes of Health Trial record 1 of 1 for: CZOL446H2409 Previous Study Return to List Next Study Efficacy Study of Zoledronic Acid and Combination Therapy in Women With
More informationUpdate on Falls Prevention Research
Update on Falls Prevention Research Jasmine Menant NSW Falls Prevention Network Rural Forum 24 th August 2018 Acknowledgements: Prof Stephen Lord, Dr Daina Sturnieks Recent falls risk factor studies Lubaszy
More information17 th WORKSHOP ON NEUROOTOLOGY. Dementia & Imbalance. DR. ATRI CHATTERJEE Assistant Professor. Neurology VMMC & SafdarJung Hospital New Delhi
17 th WORKSHOP ON NEUROOTOLOGY Dementia & Imbalance DR. ATRI CHATTERJEE Assistant Professor. Neurology VMMC & SafdarJung Hospital New Delhi ?Association Dementia Imbalance?Causation balance: An even distribution
More informationFall Prevention: Staying Active 1
FCS2232 1 Sergio Romero and Linda B. Bobroff 2 A decrease in your level of physical activity and a loss of balance and flexibility can increase your chances of falling. Other factors that may influence
More informationFall Risk factors in Chinese older people: Implications for falls prevention
Fall Risk factors in Chinese older people: Implications for falls prevention Chinese Older Peoples Study of Injury: X cultural (CHOPSTIX) 1 st June 2012 NSW Falls Prevention Network Forum Falls research
More informationIan McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University
Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University Design of trials in DLB and PDD What has been learnt from previous trials in these indications and other dementias? Overview
More informationU-ExCEL Balancing Act Manual
U-ExCEL Exercise and Conditioning for Easier Living U-ExCEL Balancing Act Manual ABRIDGED First Edition LARGE PRINT WINNER! 2012 2013 Maine Governor s Fitness Award Authors Marilyn R. Gugliucci, Ph.D.
More informationINTERVAL trial Statistical analysis plan for principal paper
INTERVAL trial Statistical analysis plan for principal paper 8 January 2016, final agreed version Compiled by Simon Thompson, on behalf of the INTERVAL Trial Steering Committee 1. Aim The purpose of this
More informationAppendix N: Research recommendations
Appendix N: recommendations N.1 First-line treatment of motor symptoms recommendation 1 Interventions What is the effectiveness of initial levodopa monotherapy versus initial levodopa-dopamine agonist
More informationForm B3L: UPDRS Part III Motor Examination 1
Initial Visit Packet NACC Uniform Data Set (UDS) LBD MODULE Form B3L: UPDRS Part III Motor Examination 1 ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to
More informationSupplementary webappendix
Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: White PD, Goldsmith KA, Johnson AL, et
More informationFalling Down: Assessing the Risk of Falls in Older Adults
Virginia Commonwealth University VCU Scholars Compass Case Studies from Age in Action Virginia Center on Aging 2013 Falling Down: Assessing the Risk of Falls in Older Adults Steven Morrison Old Dominion
More informationFall risk in people with MS: A Physiological Profile Assessment study.
University of Plymouth PEARL Faculty of Health and Human Sciences https://pearl.plymouth.ac.uk School of Health Professions 2016-01 Fall risk in people with MS: A Physiological Profile Assessment study.
More informationClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: 01/19/2016. ClinicalTrials.gov ID: NCT
ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: 01/19/2016 ClinicalTrials.gov ID: NCT00595413 Study Identification Unique Protocol ID: 27905 Brief Title: Atacicept
More informationBerg Balance Scale. Name: Date of Test:.
Berg Balance Scale Name: Date of Test:. 1. Sit to Stand Instructions: Please stand up. Try not to use your hands for support ( ) 0: Needs moderate or maximal assistance to stand ( ) 1: Needs minimal assistance
More informationEfficient analysis of ordinal functional outcome scales
Efficient analysis of ordinal functional outcome scales Gordon D Murray University of Edinburgh Outline of presentation Functional outcome scales Ordinal analysis Case study: SCAST Results Points to consider
More informationMOTOR FUNCTION MEASURE for neuromuscular diseases M F M
MOTOR FUNCTION MEASURE for neuromuscular diseases M F M SCORING SHEET 1 Patient birth s name, surname: Married name: Date of birth: / / Patient age: / year month day years months Assessment date: / / year
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent
More informationSupplementary webappendix
Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Kazui H, Miyajima M, Mori E, Ishikawa
More informationSTAIR negotiation (ascent and descent) is an important
Journal of Gerontology: MEDICAL SCIENCES 2007, Vol. 62A, No. 11, 1259 1265 Copyright 2007 by The Gerontological Society of America Physical and Psychological Factors Associated With Stair Negotiation Performance
More informationSponsor Novartis. Generic Drug Name Vildagliptin/Metformin. Therapeutic Area of Trial Type 2 diabetes. Approved Indication Type 2 diabetes
Clinical Trial Results Database Page 1 Sponsor Novartis Generic Drug Name Vildagliptin/Metformin Therapeutic Area of Trial Type 2 diabetes Approved Indication Type 2 diabetes Study Number CLMF237A2309
More informationA comparison of exercise intervention to standard care in decreasing fall risk for patients with Parkinson s disease
Pacific University CommonKnowledge PT Critically Appraised Topics School of Physical Therapy 2014 A comparison of exercise intervention to standard care in decreasing fall risk for patients with Parkinson
More informationFifth Edition. COPYRIGHT 2015~ University of New England
Fifth Edition COPYRIGHT 2015~ University of New England Acquiring the U-ExCEL Balancing Act Manual The U-ExCEL Balancing Act Manual can be purchased directly from the University of New England College
More informationID # COMPLETED: YES.. 1 DATE NO... 5 NEUROLOGICAL EXAM
ID # COMPLETED: YES.. 1 DATE NO... 5 NEUROLOGICAL EXAM VIDEOTAPED: YES.. 1 NO... 5 COMMENT: NEUROLOGICAL EXAM "Normal, Abnormal, Other, Can't execute or Missing for each question. Always complete specify
More informationUstekinumab for the treatment of moderate to severe psoriasis
DOI: 10.3310/hta13suppl3/10 Health Technology Assessment 2009; Vol. 13: Suppl. 3 Ustekinumab for the treatment of moderate to severe psoriasis E Gospodarevskaya, J Picot, K Cooper, E Loveman* and A Takeda
More informationGAIT DISORDERS ARE a distinctive feature of idiopathic
ORIGINAL ARTICLE Freezing of Gait and Activity Limitations in People With Parkinson s Disease Dawn M. Tan, M Physio, Jennifer L. McGinley, PhD, Mary E. Danoudis, M Physio, Robert Iansek, MD, PhD, Meg E.
More informationRehabilitation 2. The Exercises
Rehabilitation 2 This is the next level from rehabilitation 1. You should have spent time mastering the previous exercises and be ready to move on. If you are unsure about any of the previous exercises
More informationUpdate on Falls Prevention Research
Update on Falls Prevention Research Professor Stephen Lord Coffs Harbour Falls Prevention Network Rural Forum 28 th February 2014 Acknowledgments: Dr Jasmine Menant, Mr. Daniel Schoene Recent falls risk
More informationDoes Exercise Reduce the Risk of Falling in Parkinson s Patients?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2015 Does Exercise Reduce the Risk of Falling
More informationExpanding Access to Movement Disorders Care and Research. Kevin M. Biglan, MD, MPH Rochester, New York September 24, 2016.
Expanding Access to Movement Disorders Care and Research Kevin M. Biglan, MD, MPH Rochester, New York September 24, 2016 Disclosures Presbyterian Home of Central New York Susquehanna Nursing and Rehabilitation
More informationDeborah Behre, DPM
Deborah Behre, DPM db.foot@comcast.net NO DISCLOSURES SAVE THE DATE! SEPTEMBER 22 WHO CARES? PATIENTS FAMILY & FRIENDS YOU, YOUR STAFF AND YOUR PRACTICES THE HEALTH CARE SYSTEM (MEDICARE) CDC & WHO EVERY
More informationFall prevention research update. Professor Stephen Lord Neuroscience Research Australia University of NSW Sydney, Australia
Fall prevention research update Professor Stephen Lord Neuroscience Research Australia University of NSW Sydney, Australia Simple Predictors of Falls in Residential Care Dwellers Whitney J et al, Arch
More information5 Diagnosis. Timely diagnosis. Back to contents
5 5 Diagnosis Back to contents Study Advisory Group questions: Are there delays in diagnosis? Is there variation in how the cerebral palsies are described? signs can fluctuate, to avoid over-diagnosis
More informationCommunity-based group exercise improves balance and reduces falls in at-risk older people: a randomised controlled trial
Age and Ageing 2003; 32: 407 414 Age and Ageing Vol. 32 No. 4 # 2003, British Geriatrics Society. All rights reserved. Community-based group exercise improves balance and reduces falls in at-risk older
More informationOsteoporosis Exercise:
Osteoporosis Exercise: Balance, Posture and Functional Exercises Osteoporosis Exercise: Weight-Bearing and Muscle Strengthening Exercises Introduction You can help improve and maintain your balance, posture
More informationAnkle Sprain Rehabilitation
Ankle Sprain Rehabilitation The following exercises are commonly used for rehabilitation following an ankle sprain. However, each surgery is unique and each person s condition is unique. We recommend that
More informationClinical Study Report Assessment of Safety
Clinical Study Report Assessment of Safety Study title: Switch to RItuXimab in MS: A phase 2 open label study of Rituximab in MS patients previously treated with selfinjectibles using a target based therapy
More informationA Syndrome (Pattern) Approach to Low Back Pain. History
A Syndrome (Pattern) Approach to Low Back Pain Hamilton Hall MD FRCSC Professor, Department of Surgery, University of Toronto Medical Director, CBI Health Group Executive Director, Canadian Spine Society
More informationBecoming a PI. Dr Emily Henderson
Becoming a PI Dr Emily Henderson Consultant Geriatrician, RUH Bath Honorary Consultant Senior Lecturer, University of Bristol 1 Disclosures Research funding: Parkinson s UK, National Institute of Health
More informationPrevention (Home Care)
Prevention (Home Care) Improvements in Balance in Older Adults Engaged in a Specialized Home Care Falls Prevention Program. Whitney SL, Marchetti GF, Ellis JL, Otis L. J. Geriatr. Phys. Ther. 2012; epub(epub):
More informationSponsor. Novartis Pharmaceuticals Corporation Generic Drug Name. Agomelatine Therapeutic Area of Trial. Major depressive disorder Approved Indication
Clinical Trial Results Database Page 1 Sponsor Novartis Pharmaceuticals Corporation Generic Drug Name Therapeutic Area of Trial Major depressive disorder Approved Indication Investigational drug Study
More informationWhy Train Your Calf Muscles
Why Train Your Calf Muscles 1 Why Train Your Calf Muscles The muscles of the calf are often considered genetic muscles among fitness enthusiasts, suggesting that one is born with sizable and well developed
More informationEFFECT OF POSTURAL SWAY SCALE AS A PROGNOSTIC TOOL IN LOW BACK PAIN MANAGEMENT.
Original Research Article Allied Science International Journal of Pharma and Bio Sciences ISSN 0975-6299 EFFECT OF POSTURAL SWAY SCALE AS A PROGNOSTIC TOOL IN LOW BACK PAIN MANAGEMENT. 1 MANJULADEVI.NB.P.T,
More informationUtilizing the items from the MDS-UPDRS score to increase drug effect detection power in de novo idiopathic Parkinson's disease patients
Utilizing the items from the MDS-UPDRS score to increase drug effect detection power in de novo idiopathic Parkinson's disease patients Simon Buatois 1,3, Sylvie Retout 1, Nicolas Frey 1, Sebastian Ueckert
More informationNeurological Examination
Neurological Examination Charles University in Prague 1st Medical Faculty and General University Hospital Neurological examination: Why important? clinical history taking and bedside examination: classical
More informationScottish Medicines Consortium
Scottish Medicines Consortium rotigotine 2mg/24 hours, 4mg/24 hours, 6mg/24 hours, 8mg/24 hours transdermal patch (Neupro ) (No: 289/06) Schwarz Pharma Ltd. 7 July 2006 The Scottish Medicines Consortium
More informationClinialTrials.gov Identifier: sanofi-aventis. Sponsor/company: 07/November/2008
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinialTrials.gov
More informationResearch Update: Vitamin D and falls in older people Fall prevention in hospitals. Stephen Lord
Research Update: Vitamin D and falls in older people Fall prevention in hospitals Stephen Lord Vitamin D insufficiency, physiological and cognitive functioning and falls in older people Jasmine Menant,
More informationSupplementary Online Content
Supplementary Online Content Krebs EE, Gravely A, Nugent S, et al. Effect of opioid vs non-opioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain:
More informationPATCH Analysis Plan v1.2.doc Prophylactic Antibiotics for the Treatment of Cellulitis at Home: PATCH Analysis Plan for PATCH I and PATCH II Authors: Angela Crook, Andrew Nunn, James Mason and Kim Thomas,
More informationSFPD Physical Ability Test (PAT) Instructions and Score Table
The SFPD PAT consists of four events: 1. Dominant Handgrip 2. Sit-ups 3. Push Ups 4. Wall Agility Run SFPD Physical Ability Test (PAT) Instructions and Score Table Below are the instructions that are provided
More informationIndian Journal of Medical Research and Pharmaceutical Sciences January 2017;4(1) ISSN: ISSN: DOI: /zenodo Impact Factor: 3.
EFFICACY OF BALANCE TRAINING ON FALL IN PARKINSON S DISEASE Gharote Gaurai*, Surve Monika, Yeole Ujwal, Panse Rasika, Kulkarni Shweta & Pawar Pournima *Tilak Maharashtra, Vidyapeeth, Gultekadi, Pune Keywords:
More informationPD AND FALLS J U MALLYA FALLS AWARENESS MEETING
PD AND FALLS J U MALLYA FALLS AWARENESS MEETING 23-09-2016 PD Chronic Progressive neurodegenerative disease Motor system disorder Degeneration of Dopaminergic neurons in Substantia nigra in the midbrain.
More informationFull Novartis CTRD Results Template
Full Novartis CTRD Results Template Sponsor Novartis Generic Drug Name vildagliptin Therapeutic Area of Trial Type 2 diabetes Approved Indication Type 2 diabetes Protocol Number CLAF237A23138E1 Title A
More informationUnified Parkinson Disease Rating Scale (UPDRS)
Unified Parkinson Disease Rating Scale (UPDRS) The UPDRS is a rating tool to follow the longitudinal course of Parkinson's Disease. It is made up of the 1)Mentation, Behavior, and Mood, 2)ADL and 3)Motor
More informationPostural instability Hypokinesia Rigidity Tremor Forward flexed posture. pain million people 50+ years old 10 most populated countries
4.1-4.6 million people 50+ years old 10 most populated countries Cyndi Robinson, PT, PhD University of Washington Seattle, Washington, USA Progressive neurodegenerative disorder Selective neuronal loss
More informationFreezing or Sweating Falls When Walking with Parkinson s Disease
Freezing or Sweating Falls When Walking with Parkinson s Disease Fay B. Horak, Ph.D, PT Professor of Neurology Oregon Health & Science University Parkinson s Foundation Center of Excellence January 16,
More informationStrength and Balance Exercise Manual. Building Confidence and Reducing Falls in Older Adults. Lindy Clemson Megan Swann Jane Mahoney
Building Confidence and Reducing Falls in Older Adults Strength and Balance Exercise Manual Lindy Clemson Megan Swann Jane Mahoney 3rd North American edition Exercises BALANCE AND STRENGTH EXERCISES TO
More informationSession 3A Concurrent Risk factors and clinical conditions 1
Session 3A Concurrent Risk factors and clinical conditions Dr Teresa Liu- Ambrose, PhD is an Assistant Professor at the University of British Columbia. Her research focuses on the role of exercise in promoting
More informationAssessment and management of dementia in relation to falls risk: Tools and tips for community, hospital and residential care
Assessment and management of dementia in relation to falls risk: Tools and tips for community, hospital and residential care Professor Jacqueline CT Close Neuroscience Research Australia Prince of Wales
More informationContinuous dopaminergic stimulation
Continuous dopaminergic stimulation Angelo Antonini Milan, Italy GPSRC CNS 172 173 0709 RTG 1 As PD progresses patient mobility becomes increasingly dependent on bioavailability of peripheral levodopa
More informationStudy No Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable(s):
Studies listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationGait Disorders. Nicholas J. Silvestri, MD
Gait Disorders Nicholas J. Silvestri, MD Disclosures NO SIGNIFICANT FINANCIAL, GENERAL, OR OBLIGATION INTERESTS TO REPORT Learning Objectives Explain the normal development of gait Describe various gait
More information